Targeted
Cancer Therapeutics
Polymed
Therapeutics is a US-based biopharmaceutical company committed
to the development of an integrated portfolio of oncology products,
technologies and proprietary formulations aimed at making treatment
of cancer more effective. The company's ppbTM technology platform relates to the novel use of a polypeptide
bound to a drug to act as a targeted drug carrier, which can improve
drug solubility and provide higher therapeutic efficacy in cancer
treatment. POLYMED's core research & development is based
in the US while its new technologies and drugs are deployed exclusively
to the ever-growing pharmaceutical market in the People's Republic
of China.
